Vaxart, Inc. (VXRT)
0.3647
0.00 (0.00%)
USD |
OTCM |
Dec 11, 15:51
Vaxart EPS Diluted (Quarterly): -0.0356 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bionano Genomics, Inc. | -1.593 |
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.141M |
| Revenue (Quarterly) | 72.41M |
| Total Expenses (Quarterly) | 80.55M |
| Enterprise Value | 77.55M |
| Gross Profit Margin (Quarterly) | 97.13% |
| Profit Margin (Quarterly) | -11.24% |
| Earnings Yield | -60.93% |
| Normalized Earnings Yield | -60.93 |